Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamun Al-Mahtab

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current StatusPartho Pratik Roy, Mamun Al Mahtab, Mohammad Abdur Rahim, et al.
Vaccines|May 28, 2022
Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to BedsideSheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan, et al.
Journal of Global Health|December 4, 2020
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakersMd Sakirul Islam Khan, Hiroaki Nabeka, Sheikh Mohammad Fazle Akbar, et al.
Frontiers in Medicine|February 27, 2023
Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatmentMamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical TrialSheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2017
Hepatitis B Core Antigen in Hepatocytes of Chronic Hepatitis B: Comparison between Indirect Immunofluorescence and Immunoperoxidase MethodRuksana Raihan, Shahina Tabassum, Mamun Al-Mahtab, et al.
Euroasian Journal of Hepato-Gastroenterology|July 28, 2021
Clinical Manifestations of Hospitalized COVID-19 Patients in Bangladesh: A 14-day Observational StudyModhusudon Shaha, Md A Islam, Faizul Huq, et al.
Microbes and Infection|December 28, 2023
Genomic features and pathophysiological impact of a multidrug-resistant Staphylococcus warneri variant in murine mastitisM Nazmul Hoque, Golam Mahbub Faisal, Ziban Chandra Das, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Gender Differences in Nonalcoholic Fatty Liver DiseaseAabha Nagral, Manisha Bangar, Sherna Menezes, et al.
Euroasian Journal of Hepato-Gastroenterology|January 29, 2021
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in BangladeshMd Azizul Islam, Masudul A Mazumder, Neelima Akhter, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current StatusPartho Pratik Roy, Mamun Al Mahtab, Mohammad Abdur Rahim, et al.
Vaccines|May 28, 2022
Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to BedsideSheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan, et al.
Journal of Global Health|December 4, 2020
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakersMd Sakirul Islam Khan, Hiroaki Nabeka, Sheikh Mohammad Fazle Akbar, et al.
Frontiers in Medicine|February 27, 2023
Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatmentMamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical TrialSheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2017
Hepatitis B Core Antigen in Hepatocytes of Chronic Hepatitis B: Comparison between Indirect Immunofluorescence and Immunoperoxidase MethodRuksana Raihan, Shahina Tabassum, Mamun Al-Mahtab, et al.
Euroasian Journal of Hepato-Gastroenterology|July 28, 2021
Clinical Manifestations of Hospitalized COVID-19 Patients in Bangladesh: A 14-day Observational StudyModhusudon Shaha, Md A Islam, Faizul Huq, et al.
Microbes and Infection|December 28, 2023
Genomic features and pathophysiological impact of a multidrug-resistant Staphylococcus warneri variant in murine mastitisM Nazmul Hoque, Golam Mahbub Faisal, Ziban Chandra Das, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Gender Differences in Nonalcoholic Fatty Liver DiseaseAabha Nagral, Manisha Bangar, Sherna Menezes, et al.
Euroasian Journal of Hepato-Gastroenterology|January 29, 2021
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in BangladeshMd Azizul Islam, Masudul A Mazumder, Neelima Akhter, et al.
Pageof 17